Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Endocrinol (Lausanne). 2022 Oct 20;13:1025706. doi: 10.3389/fendo.2022.1025706. eCollection 2022.
Obesity is a global epidemic characterized by energy disequilibrium, metabolic disorder, fat mass development, and chronic low-grade inflammation, which significantly affects the health state of individuals of all ages and strains the socioeconomic system. The prevalence of obesity is rising at alarming rates and its etiology involves complicated interplay of diet, genetic, and environmental factors. The gut microbiota, as an important constituent of environmental factors, has been confirmed to correlate with the onset and progression of obesity. However, the specific relationship between obesity and the gut microbiota, and its associated mechanisms, have not been fully elucidated. In this review, we have summarized that the microbial diversity was significantly decreased and the Firmicutes/Bacteroidetes ratio was significantly increased in obesity. The altered gut microbiota and associated metabolites contributed to the progression of the disease by disrupting energy homeostasis, promoting lipid synthesis and storage, modulating central appetite and feeding behavior, as well as triggering chronic inflammation, and that the intentional manipulation of gut microbiota held promise as novel therapies for obesity, including probiotics, prebiotics, and fecal microbiota transplantation.
肥胖是一种全球性的流行病,其特征是能量失衡、代谢紊乱、脂肪量增加和慢性低度炎症,这显著影响了各个年龄段人群的健康状况,并给社会经济系统带来压力。肥胖的流行率正在以惊人的速度上升,其病因涉及饮食、遗传和环境因素的复杂相互作用。肠道微生物群作为环境因素的重要组成部分,已被证实与肥胖的发生和发展有关。然而,肥胖与肠道微生物群之间的具体关系及其相关机制尚未完全阐明。在这篇综述中,我们总结到肥胖症患者的微生物多样性显著降低,厚壁菌门/拟杆菌门的比例显著增加。改变的肠道微生物群及其相关代谢产物通过破坏能量平衡、促进脂质合成和储存、调节中枢食欲和摄食行为以及引发慢性炎症来促进疾病的发展,而对肠道微生物群的有意操纵有望成为肥胖症的新型治疗方法,包括益生菌、益生元和粪便微生物移植。